Hans-Georg Kuhn

Title: Innovations of Hans-Georg Kuhn

Introduction

Hans-Georg Kuhn is a notable inventor based in Billdal, Sweden. He has made significant contributions to the field of biotechnology, particularly in the area of neuronal determined cells. With a total of 3 patents to his name, his work has implications for both research and therapeutic applications.

Latest Patents

Kuhn's latest patents focus on the use of regulatory sequences for specific, transient expression in proliferative neuronal determined cells. These inventions detail methods for mediating early transient expression in these cells, as well as the generation of non-human transgenic organisms and host cells. His patents also describe methods for preparing vectors, host cells, and transgenic animals, along with techniques for detecting and isolating neuronal determined cells. Furthermore, the inventions provide methods for screening compounds that can regulate neuronal activity and neurogenesis, which are crucial for understanding neuronal differentiation and migration processes. The patents also encompass diagnostic and pharmaceutical compositions that utilize the described regulatory sequences and recombinant nucleic acid molecules.

Career Highlights

Hans-Georg Kuhn is associated with F. Hoffmann-La Roche AG, a leading company in the pharmaceutical and biotechnology sectors. His work at Roche has allowed him to contribute to groundbreaking research and development in the field of neuroscience.

Collaborations

Kuhn has collaborated with notable colleagues, including Claudia Karl and Ludwig Aigner. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Hans-Georg Kuhn's contributions to the field of biotechnology, particularly through his patents related to neuronal determined cells, highlight his role as an influential inventor. His work continues to pave the way for advancements in neuroscience and therapeutic applications.